These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2868999)

  • 1. Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
    Török E; Kósa E; Szontagh M; Juvancz P; Eggenhofer J; Borvendég J
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):650-6. PubMed ID: 2868999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of methods to detect side-effect on clinical application of chloranolol, a beta-adrenergic receptor inhibitor.
    Török E; Kósa E; Szontagh M; Juvancz P; Eggenhofer J; Borvendég J
    Eur J Clin Pharmacol; 1984; 26(5):555-62. PubMed ID: 6147256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
    Szám I; Büky P; Gulyás A; Sinkovics M
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].
    Burkart F; Stamm G; Witassek F
    Schweiz Med Wochenschr; 1989 May; 119(18):575-81. PubMed ID: 2568685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term studies on the beta blocker talinolol (cordanum) with special reference to side effects].
    Mann D; Boguschewski KD; Brämer U; Dobritz H; Hitzeroth T
    Z Gesamte Inn Med; 1979 Apr; 34(7):192-5. PubMed ID: 39387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
    Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 10. [New specialty drugs registered in Austria. Concor].
    Graffius D
    Wien Klin Wochenschr; 1990 Mar; 102(6):180-4. PubMed ID: 1970446
    [No Abstract]   [Full Text] [Related]  

  • 11. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 13. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas.
    Sipos Z; Hollósi Z; Iskum M
    Ther Hung; 1984; 32(2):74-8. PubMed ID: 6152819
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisoprolol--another cardioselective beta blocker.
    Drug Ther Bull; 1989 Jul; 27(14):55-6. PubMed ID: 2577508
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety profile of bevantolol.
    Bray JS
    Angiology; 1986 Mar; 37(3 Pt 2):248-53. PubMed ID: 2871785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta blocker therapy. New aspects--outdated opinions. Interview by G. Riecker].
    Werdan K
    Internist (Berl); 1992 Sep; 33(9):618-21. PubMed ID: 1356943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy and differential therapy with beta sympathicolytic drugs].
    Frisch P
    Med Klin; 1975 Oct; 70(42):1682-7. PubMed ID: 241898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.